Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research evaluation to study individuals who show thromboxane or P2Y12 receptor resistance

Trial Profile

Research evaluation to study individuals who show thromboxane or P2Y12 receptor resistance

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Eptifibatide; Heparin
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Feb 2013 Planned number of patients changed from 600 to 1200 as reported by ClinicalTrials.gov.
    • 19 Jul 2007 Status changed from recruiting to discontinued. Sponsor support withdrawn.
    • 21 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top